|
시장보고서
상품코드
1762279
동물 신경변성질환 진단 시장, 시장 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 검사별, 동물 유형별, 적응증별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Veterinary Neurodegenerative Disease Diagnostics Market Size, Share, Trends, & Industry Analysis Report By Product, By Test, By Animal Type, By Indication, By End Use, and By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 동물 신경변성질환 진단 시장 규모는 2034년까지 8억 579만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 상세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
동물 신경변성질환 진단은 광범위한 동물 헬스케어 산업 중에서도 동물의 신경변성질환의 발견과 관리에 초점을 맞춘 전문 분야입니다. 개의 인지기능장애증후군(CDS), 고양이의 치매, 말의 운동신경세포질환과 같은 신경변성질환은 노령화되는 반려동물과 가축의 심각한 건강 문제로 인식되고 있습니다. 조기에 정확한 진단은 이러한 질병을 관리하고, 동물 복지를 개선하며, 삶의 질을 향상시키는 데 매우 중요합니다.
이 시장에는 첨단 영상 진단 기술, 뇌척수액(CSF) 분석, 유전자 치료, 바이오마커 평가 등 다양한 진단 도구가 포함됩니다. 동물의 신경질환에 대한 인식이 높아지고 수의학 진단학의 발전과 함께 시장 확대의 원동력이 되고 있습니다. 또한, 반려동물을 가족의 일원으로 여기는 '반려동물의 인간화' 트렌드의 증가는 고급 수의학에 대한 지출 증가로 이어져 신경변성질환 진단약에 대한 수요를 더욱 촉진하고 있습니다.
동물 신경변성질환 진단 시장 보고서 하이라이트
제품별로는 동물 신경질환의 조기 발견과 정확한 진단에 필수적인 역할을 하는 소모품, 시약, 키트 분야가 2024년 큰 비중을 차지했습니다.
검사별로는 동물의 뇌와 척수 이상을 확인하는 데 중요한 역할을 하는 이미징 부문이 2024년 시장 점유율을 독차지했습니다.
동물 유형별로는 반려동물, 특히 개와 고양이의 신경질환 유병률 증가로 인해 반려동물 부문이 2024년 가장 큰 점유율을 차지했습니다.
북미 동물용 신경변성질환 진단 시장은 2024년 반려동물, 특히 개와 고양이 집단에서 신경변성질환의 유병률 증가로 인해 가장 큰 점유율을 차지했습니다.
유럽 시장은 반려동물의 노령인구 증가와 신경질환에 대한 인식이 높아짐에 따라 향후 몇 년 동안 견조한 성장세를 보일 것으로 예상됩니다.
아시아태평양 시장은 반려동물 사육 증가, 가처분 소득 증가, 수의학 의료 인프라 개선으로 인해 2034년까지 상당한 점유율을 차지할 것으로 예상됩니다.
세계 주요 시장 기업에는 ACUVET BIOTECH, Antech Diagnostics, Inc., Avacta Animal Health Limited, Heska Corporation, IDEXX Laboratories, Inc., Life Diagnostics, Merck & Co., Inc., Mercodia AB, MI:RNA Diagnostics Ltd., Virbac, Zoetis. 등이 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 동물 신경변성질환 진단 시장 인사이트
- 적응 현황
- 동물 신경변성질환 진단 시장 역학
- 성장 촉진요인과 기회
- 세계에서 가처분 소득이 증가
- 수의 신경학의 기술적 진보
- 성장 억제요인과 과제
- 보편적으로 수용되고 있는 진단 검사의 결여
- 성장 촉진요인과 기회
- PESTEL 분석
- 동물 신경변성질환 진단 시장 동향
- 밸류체인 분석
제5장 세계의 동물 신경변성질환 진단 시장 : 제품별
- 주요 조사 결과
- 소개
- 소모품, 시약, 키트
- 기기와 기구
제6장 세계의 동물 신경변성질환 진단 시장 : 검사별
- 주요 조사 결과
- 소개
- 영상 진단
- 바이오마커 진단 검사
- 기타
제7장 세계의 동물 신경변성질환 진단 시장 : 동물 유형별
- 주요 조사 결과
- 소개
- 가축
- 반려
제8장 세계의 동물 신경변성질환 진단 시장 : 적응증별
- 주요 조사 결과
- 소개
- 인지기능장애
- 소뇌 위축증
- 해면상 뇌병증
- 기타
제9장 세계의 동물 신경변성질환 진단 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 동물 병원과 진료소
- 수의 진단 연구소
- 기타
제10장 세계의 동물 신경변성질환 진단 시장 : 지역별
- 주요 조사 결과
- 소개
- 동물 신경변성질환 진단 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 제품별, 2020-2034년
- 북미 : 검사별, 2020-2034년
- 북미 : 동물 유형별, 2020-2034년
- 북미 : 적응증별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별, 2020-2034년
- 유럽 : 검사별, 2020-2034년
- 유럽 : 동물 유형별, 2020-2034년
- 유럽 : 적응증별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 검사별, 2020-2034년
- 아시아태평양 : 동물 유형별, 2020-2034년
- 아시아태평양 : 적응증별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 검사별, 2020-2034년
- 중동 및 아프리카 : 동물 유형별, 2020-2034년
- 중동 및 아프리카 : 적응증별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 검사별, 2020-2034년
- 라틴아메리카 : 동물 유형별, 2020-2034년
- 라틴아메리카 : 적응증별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제11장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제12장 기업 개요
- ACUVET BIOTECH
- Antech Diagnostics, Inc.
- Avacta Animal Health Limited
- Heska Corporation
- IDEXX Laboratories, Inc.
- Life Diagnostics
The veterinary neurodegenerative disease diagnostics market size is expected to reach USD 805.79 million by 2034, according to a new study by Polaris Market Research. The report "Veterinary Neurodegenerative Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Consumables, Reagents & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The veterinary neurodegenerative disease diagnostics is a specialized sector within the broader veterinary healthcare industry, focusing on the detection and management of neurodegenerative disorders in animals. Neurodegenerative diseases such as cognitive dysfunction syndrome (CDS) in dogs, feline dementia, and equine motor neuron disease are increasingly recognized as serious health concerns in aging pets and livestock. Early and accurate diagnosis is crucial for managing these conditions, improving animal welfare, and extending quality of life.
The market encompasses various diagnostic tools, including advanced imaging techniques, cerebrospinal fluid (CSF) analysis, gene therapy, and biomarker assessments. The growing awareness of neurological disorders in animals, coupled with advancements in veterinary diagnostics, is driving market expansion. Additionally, the rising trend of pet humanization, where pets are considered family members, is leading to increased spending on advanced veterinary care, further propelling demand for neurodegenerative disease diagnostics.
Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights
In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.
Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.
In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.
The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.
The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.
The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.
A few global key market players include ACUVET BIOTECH; Antech Diagnostics, Inc.; Avacta Animal Health Limited; Heska Corporation; IDEXX Laboratories, Inc.; Life Diagnostics; Merck & Co., Inc.; Mercodia AB; MI:RNA Diagnostics Ltd.; Virbac; and Zoetis.
Polaris Market Research has segmented the veterinary neurodegenerative disease diagnostics market report on the basis of product, test, animal type, indication, end use, and region:
By Product Outlook (Revenue, USD Million, 2020-2034)
Consumables, Reagents & Kits
Equipment & Instruments
By Test Outlook (Revenue, USD Million, 2020-2034)
Imaging
MRI (Magnetic Resonance Imaging)
CT (Computed Tomography)
Others
Biomarker Diagnostic Tests
CSF (Cerebrospinal Fluid) biomarkers
Blood-based biomarkers
Others
Others
By Animal Type Outlook (Revenue, USD Million, 2020-2034)
Livestock
Sheep
Cattle
Others
Companion
Canine
Feline
Equine
Others
By Indication Outlook (Revenue, USD Million, 2020-2034)
Cognitive Dysfunction
Cerebellar Abiotrophy
Spongiform Encephalopathies
Others
By End Use Outlook (Revenue, USD Million, 2020-2034
Veterinary Hospitals and Clinics
Veterinary Diagnostic Laboratories
Others
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Veterinary Neurodegenerative Disease Diagnostics Market Insights
- 4.1. Veterinary Neurodegenerative Disease Diagnostics Market - Indication Snapshot
- 4.2. Veterinary Neurodegenerative Disease Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Disposable Income Worldwide
- 4.2.1.2. Technological Advancements in Veterinary Neurology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of a universally accepted diagnostic test
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Veterinary Neurodegenerative Disease Diagnostics Market Trends
- 4.6. Value Chain Analysis
5. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 5.3. Consumables, Reagents & Kits
- 5.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Consumables, Reagents & Kits, by Region, 2020-2034 (USD Million)
- 5.4. Equipment & Instruments
- 5.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Equipment & Instruments, by Region, 2020-2034 (USD Million)
6. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 6.3. Imaging
- 6.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Imaging, by Region, 2020-2034 (USD Million)
- 6.3.2. MRI (Magnetic Resonance Imaging)
- 6.3.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by MRI (Magnetic Resonance Imaging), by Region, 2020-2034 (USD Million)
- 6.3.3. CT (Computed Tomography)
- 6.3.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by CT (Computed Tomography), by Region, 2020-2034 (USD Million)
- 6.3.4. Others
- 6.3.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
- 6.4. Biomarker Diagnostic Test
- 6.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Biomarker Diagnostic Test, by Region, 2020-2034 (USD Million)
- 6.4.2. CSF (Cerebrospinal Fluid) biomarkers
- 6.4.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by CSF (Cerebrospinal Fluid) biomarkers, by Region, 2020-2034 (USD Million)
- 6.4.3. Blood-based biomarkers
- 6.4.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Blood-based biomarkers, by Region, 2020-2034 (USD Million)
- 6.4.4. Others
- 6.4.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
- 6.5. Others
- 6.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
7. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 7.3. Livestock
- 7.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Livestock, by Region, 2020-2034 (USD Million)
- 7.3.2. Sheep
- 7.3.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Sheep, by Region, 2020-2034 (USD Million)
- 7.3.3. Cattle
- 7.3.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Cattle, by Region, 2020-2034 (USD Million)
- 7.3.4. Others
- 7.3.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Others, by Region, 2020-2034 (USD Million)
- 7.4. Companion
- 7.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Companion, by Region, 2020-2034 (USD Million)
- 7.4.2. Canine
- 7.4.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Canine, by Region, 2020-2034 (USD Million)
- 7.4.3. Feline
- 7.4.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Feline, by Region, 2020-2034 (USD Million)
- 7.4.4. Equine
- 7.4.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Equine, by Region, 2020-2034 (USD Million)
- 7.4.5. Others
- 7.4.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, Others, by Region, 2020-2034 (USD Million)
8. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 8.3. Cognitive Dysfunction
- 8.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Cognitive Dysfunction, by Region, 2020-2034 (USD Million)
- 8.4. Cerebellar Abiotrophy
- 8.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Cerebellar Abiotrophy, by Region, 2020-2034 (USD Million)
- 8.5. Spongiform Encephalopathies
- 8.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Spongiform Encephalopathies, by Region, 2020-2034 (USD Million)
- 8.6. Others
- 8.6.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
9. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 9.3. Veterinary Hospitals and Clinics
- 9.3.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Veterinary Hospitals and Clinics, by Region, 2020-2034 (USD Million)
- 9.4. Veterinary Diagnostic Laboratories
- 9.4.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Veterinary Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
- 9.5. Others
- 9.5.1. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)
10. Global Veterinary Neurodegenerative Disease Diagnostics Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Veterinary Neurodegenerative Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
- 10.3. Veterinary Neurodegenerative Disease Diagnostics Market - North America
- 10.3.1. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.3.2. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.3.3. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.3.4. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.3.5. North America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.3.7. Veterinary Neurodegenerative Disease Diagnostics Market - U.S.
- 10.3.7.1. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.3.7.2. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.3.7.3. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.3.7.4. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.3.7.5. U.S.: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.3.8. Veterinary Neurodegenerative Disease Diagnostics Market - Canada
- 10.3.8.1. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.3.8.2. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.3.8.3. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.3.8.4. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.3.8.5. Canada: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4. Veterinary Neurodegenerative Disease Diagnostics Market - Europe
- 10.4.1. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.2. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.3. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.4. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.5. Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.6. Veterinary Neurodegenerative Disease Diagnostics Market - UK
- 10.4.6.1. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.6.2. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.6.3. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.6.4. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.6.5. UK: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.7. Veterinary Neurodegenerative Disease Diagnostics Market - France
- 10.4.7.1. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.7.2. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.7.3. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.7.4. France: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.7.5. France: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.8. Veterinary Neurodegenerative Disease Diagnostics Market - Germany
- 10.4.8.1. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.8.2. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.8.3. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.8.4. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.8.5. Germany: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.9. Veterinary Neurodegenerative Disease Diagnostics Market - Italy
- 10.4.9.1. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.9.2. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.9.3. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.9.4. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.9.5. Italy: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.10. Veterinary Neurodegenerative Disease Diagnostics Market - Spain
- 10.4.10.1. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.10.2. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.10.3. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.10.4. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.10.5. Spain: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.11. Veterinary Neurodegenerative Disease Diagnostics Market - Netherlands
- 10.4.11.1. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.11.2. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.11.3. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.11.4. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.11.5. Netherlands: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.12. Veterinary Neurodegenerative Disease Diagnostics Market - Russia
- 10.4.12.1. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.12.2. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.12.3. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.12.4. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.12.5. Russia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.4.13. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Europe
- 10.4.13.1. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.4.13.2. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.4.13.3. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.4.13.4. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.4.13.5. Rest of Europe: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5. Veterinary Neurodegenerative Disease Diagnostics Market - Asia Pacific
- 10.5.1. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.2. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.3. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.4. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.5. Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.6. Veterinary Neurodegenerative Disease Diagnostics Market - China
- 10.5.6.1. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.6.2. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.6.3. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.6.4. China: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.6.5. China: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.7. Veterinary Neurodegenerative Disease Diagnostics Market - India
- 10.5.7.1. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.7.2. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.7.3. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.7.4. India: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.7.5. India: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.8. Veterinary Neurodegenerative Disease Diagnostics Market - Malaysia
- 10.5.8.1. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.8.2. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.8.3. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.8.4. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.8.5. Malaysia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.9. Veterinary Neurodegenerative Disease Diagnostics Market - Japan
- 10.5.9.1. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.9.2. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.9.3. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.9.4. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.9.5. Japan: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.10. Veterinary Neurodegenerative Disease Diagnostics Market - Indonesia
- 10.5.10.1. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.10.2. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.10.3. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.10.4. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.10.5. Indonesia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.11. Veterinary Neurodegenerative Disease Diagnostics Market - South Korea
- 10.5.11.1. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.11.2. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.11.3. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.11.4. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.11.5. South Korea: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.12. Veterinary Neurodegenerative Disease Diagnostics Market - Australia
- 10.5.12.1. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.12.2. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.12.3. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.12.4. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.12.5. Australia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.5.13. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.5.13.2. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.5.13.3. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.5.13.4. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.5.13.5. Rest of Asia Pacific: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.6. Veterinary Neurodegenerative Disease Diagnostics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.6.2. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.6.3. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.6.4. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.6.5. Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.6.6. Veterinary Neurodegenerative Disease Diagnostics Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.6.6.2. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.6.6.3. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.6.6.4. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.6.6.5. Saudi Arabia: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.6.7. Veterinary Neurodegenerative Disease Diagnostics Market - UAE
- 10.6.7.1. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.6.7.2. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.6.7.3. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.6.7.4. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.6.7.5. UAE: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.6.8. Veterinary Neurodegenerative Disease Diagnostics Market - Israel
- 10.6.8.1. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.6.8.2. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.6.8.3. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.6.8.4. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.6.8.5. Israel: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.6.9. Veterinary Neurodegenerative Disease Diagnostics Market - South Africa
- 10.6.9.1. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.6.9.2. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.6.9.3. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.6.9.4. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.6.9.5. South Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.6.10. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.6.10.2. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.6.10.3. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.6.10.4. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.6.10.5. Rest of Middle East & Africa: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.7. Veterinary Neurodegenerative Disease Diagnostics Market - Latin America
- 10.7.1. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.7.2. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.7.3. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.7.4. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.7.5. Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.7.6. Veterinary Neurodegenerative Disease Diagnostics Market - Mexico
- 10.7.6.1. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.7.6.2. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.7.6.3. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.7.6.4. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.7.6.5. Mexico: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.7.7. Veterinary Neurodegenerative Disease Diagnostics Market - Brazil
- 10.7.7.1. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.7.7.2. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.7.7.3. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.7.7.4. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.7.7.5. Brazil: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.7.8. Veterinary Neurodegenerative Disease Diagnostics Market - Argentina
- 10.7.8.1. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.7.8.2. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.7.8.3. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.7.8.4. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.7.8.5. Argentina: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 10.7.9. Veterinary Neurodegenerative Disease Diagnostics Market - Rest of Latin America
- 10.7.9.1. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2020-2034 (USD Million)
- 10.7.9.2. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Test, 2020-2034 (USD Million)
- 10.7.9.3. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Animal Type, 2020-2034 (USD Million)
- 10.7.9.4. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2020-2034 (USD Million)
- 10.7.9.5. Rest of Latin America: Veterinary Neurodegenerative Disease Diagnostics Market, by End Use, 2020-2034 (USD Million)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. ACUVET BIOTECH
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Antech Diagnostics, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Avacta Animal Health Limited
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Heska Corporation
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. IDEXX Laboratories, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Life Diagnostics
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Pro
샘플 요청 목록